Attached files
file | filename |
---|---|
10-Q - 10-Q - SPRUCE BIOSCIENCES, INC. | sprb-10q_20200930.htm |
EX-32.2 - EX-32.2 - SPRUCE BIOSCIENCES, INC. | sprb-ex322_26.htm |
EX-31.2 - EX-31.2 - SPRUCE BIOSCIENCES, INC. | sprb-ex312_72.htm |
EX-31.1 - EX-31.1 - SPRUCE BIOSCIENCES, INC. | sprb-ex311_74.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Spruce Biosciences, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: November 18, 2020 |
|
By: |
/s/ Richard King |
|
|
|
Richard King Chief Executive Officer (Principal Executive Officer) |